文献速递肝病消化内镜

内镜超声引导剪切波测量肝脾评估肝纤维化的前瞻性临床试验

A prospective clinical trial of endoscopic ultrasound-guided shear wave measurement of liver and spleen for hepatic fibrosis.
PubMed 文献 · Gastrointest Endosc · 2026-09-09

这项单中心前瞻性临床试验于2025年1月至10月纳入109例接受EUS引导肝活检并同步行肝脾EUS-SWM的患者,以组织学纤维化为参考标准。结果显示肝E值与组织学纤维化强相关,右叶VsN高于左叶,脾硬度对肝硬化诊断AUC达0.962,EUS-SWM诊断肝硬化准确性优于APRI和FIB-4。

要点

  • EUS-SWM肝E值与组织学纤维化强相关,对肝硬化诊断准确性优异。
  • 右叶测量可靠性高于左叶,过度探头压力仅降低左叶E值。
  • 脾SWM对肝硬化有附加诊断价值,但对中间期纤维化价值有限。

核心结论

  • EUS-SWM对肝硬化具有优异诊断准确性,并与组织学纤维化相关。
  • 左叶测量可靠性较低,但两叶整体诊断性能相当,过度探头压力影响轻微。
  • 脾SWM对检测肝硬化有附加价值,但对中间期纤维化无附加价值。

研究设计与样本

  • 单中心前瞻性临床试验,2025年1月至10月纳入109例接受EUS引导肝活检并同步行肝脾EUS-SWM的患者。
  • 平均年龄58±15.9岁,女性63例。
  • 肝两叶分别在标准和过度探头压力下测量,每部位获取10次弹性测量值,可靠性定义为VsN>60%。
  • 以组织学纤维化为参考标准,统计采用配对t检验、Pearson相关和ROC曲线下面积评估。

主要发现

  • 肝E值与组织学纤维化强相关:左叶r=0.837-0.872,右叶r=0.748-0.766。
  • 右叶VsN高于左叶(93.6±8.9 vs 84.1±8.8;P<.001)。
  • 过度探头压力降低左叶E值(P=.02),但不影响右叶测量及两叶VsN。
  • 脾硬度 consistently 高于肝硬度(30.1±7.8 kPa;P<.01),对肝硬化诊断AUC为0.962。
  • F2-F3纤维化时肝SWM达中等准确性并优于脾SWM;EUS-SWM检测肝硬化准确性超过APRI和FIB-4;标准压力下操作者经验不影响测量可靠性。

临床怎么用

  • EUS-SWM可用于EUS引导肝活检同期无创评估肝纤维化,尤其对肝硬化诊断价值高。
  • 测量时优先采用右叶以获得更高可靠性,并避免过度探头压力对左叶E值的影响。
  • 脾SWM可作为肝硬化检测的补充,但不推荐用于中间期纤维化评估。

局限性

  • 单中心研究,样本量109例,外推性需多中心验证。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Endoscopic ultrasound-guided shear wave measurement (EUS-SWM) is a novel method for assessing hepatic fibrosis. We assessed its diagnostic accuracy, reproducibility, and the impact of transducer pressure. In addition, EUS-SWM of the spleen was performed to assess the correlation with liver fibrosis. METHODS: Between January and October 2025, this single-center, prospective clinical trial enrolled patients undergoing EUS-guided liver biopsy for concomitant EUS-SWM of the liver and spleen. Measurements of both hepatic lobes were obtained using standard and excessive transducer pressure. For each site, 10 elasticity measurements (E values) were acquired, with reliability defined as a velocity signal-to-noise ratio (VsN) >60%. Histologic fibrosis served as the reference standard. Statistical analyses included paired t tests, Pearson correlation, and area under the receiver operating characteristic curve evaluation for fibrosis staging. RESULTS: EUS-SWM in 109 participants (mean age, 58 ± 15.9 years; 63 women) demonstrated that E values from both hepatic lobes correlated strongly with histologic fibrosis (left lobe: r = 0.837-0.872; right lobe: r = 0.748-0.766). Right lobe measurements showed higher VsN than the left lobe (93.6 ± 8.9 vs 84.1 ± 8.8; P < .001). Excessive transducer pressure reduced left lobe E values (P = .02) but did not affect right lobe measurements or VsN in either lobe. Splenic stiffness was consistently higher than hepatic stiffness (30.1 ± 7.8 kPa; P < .01) and demonstrated excellent diagnostic performance for cirrhosis (area under the curve, 0.962). For F2-F3 fibrosis, hepatic SWM achieved moderate accuracy, outperforming splenic SWM. EUS-SWM exceeded the diagnostic accuracy of the aspartate aminotransferase to platelet ratio index and fibrosis-4 index for liver fibrosis for the detection of cirrhosis. Operator experience did not significantly influence measurement reliability under standard pressure. CONCLUSIONS: EUS-SWM has excellent accuracy for cirrhosis and correlates with histologic fibrosis. Although left lobe measurements are less reliable, overall diagnostic performance is comparable across lobes, and excessive transducer pressure has minimal impact. Splenic SWM adds value for detecting cirrhosis but not intermediate fibrosis.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Kohli DR, Smith P, Simanonok MP, et al. A prospective clinical trial of endoscopic ultrasound-guided shear wave measurement of liver and spleen for hepatic fibrosis. Gastrointest Endosc. 2026. PMID: 42716258. doi:10.1016/j.gie.2026.09.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。